» Articles » PMID: 35590028

Adaptation of the Gut Pathobiont Enterococcus Faecalis to Deoxycholate and Taurocholate Bile Acids

Overview
Journal Sci Rep
Specialty Science
Date 2022 May 19
PMID 35590028
Authors
Affiliations
Soon will be listed here.
Abstract

Enterococcus faecalis is a natural inhabitant of the human gastrointestinal tract. This bacterial species is subdominant in a healthy physiological state of the gut microbiota (eubiosis) in adults, but can become dominant and cause infections when the intestinal homeostasis is disrupted (dysbiosis). The relatively high concentrations of bile acids deoxycholate (DCA) and taurocholate (TCA) hallmark eubiosis and dysbiosis, respectively. This study aimed to better understand how E. faecalis adapts to DCA and TCA. We showed that DCA impairs E. faecalis growth and possibly imposes a continuous adjustment in the expression of many essential genes, including a majority of ribosomal proteins. This may account for slow growth and low levels of E. faecalis in the gut. In contrast, TCA had no detectable growth effect. The evolving transcriptome upon TCA adaptation showed the early activation of an oligopeptide permease system (opp2) followed by the adjustment of amino acid and nucleotide metabolisms. We provide evidence that TCA favors the exploitation of oligopeptide resources to fuel amino acid needs in limiting oligopeptide conditions. Altogether, our data suggest that the combined effects of decreased DCA and increased TCA concentrations can contribute to the rise of E. faecalis population during dysbiosis.

Citing Articles

Antibacterial Potential of Honeybee Venom and Extracellular Metabolites Against Multidrug-Resistant Pathogenic Bacteria.

Teiba I, Mazrou Y, Makhlouf A, Nehela Y, Mohamed A, Abbas A Biology (Basel). 2025; 14(1).

PMID: 39857252 PMC: 11759185. DOI: 10.3390/biology14010021.


Potentially probiotic NPL 1334 strain of Enterococcus durans benefits rats with diet-induced hypercholesterolemia.

Rashid H, Anwar H, Baig F, Mukhtar I, Muhammad T, Zaidi A BMC Biotechnol. 2025; 25(1):7.

PMID: 39825321 PMC: 11740586. DOI: 10.1186/s12896-024-00943-5.


Evaluating the antibacterial efficacy of bee venom against multidrug-resistant pathogenic bacteria: Escherichia coli, Salmonella typhimurium, and Enterococcus faecalis.

El-Bilawy E, Mamdouh I, Behiry S, Teiba I World J Microbiol Biotechnol. 2025; 41(2):40.

PMID: 39821511 PMC: 11739217. DOI: 10.1007/s11274-024-04248-9.


Antimicrobial activity of Monascus purpureus-derived red pigments against Salmonella typhimurium, Escherichia coli, and Enterococcus faecalis.

Teiba I, Mamdouh I, Yousef M, Hussein A, El-Bilawy E AMB Express. 2025; 15(1):6.

PMID: 39755819 PMC: 11700071. DOI: 10.1186/s13568-024-01801-5.


Unexpected vulnerability of to polymyxin B under anaerobic condition.

Son Y, Kim B, Kim P, Min J, Park Y, Yang J Gut Microbes. 2024; 16(1):2438465.

PMID: 39663231 PMC: 11651277. DOI: 10.1080/19490976.2024.2438465.


References
1.
Ridlon J, Harris S, Bhowmik S, Kang D, Hylemon P . Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016; 7(1):22-39. PMC: 4856454. DOI: 10.1080/19490976.2015.1127483. View

2.
Chiang J . Bile acids: regulation of synthesis. J Lipid Res. 2009; 50(10):1955-66. PMC: 2739756. DOI: 10.1194/jlr.R900010-JLR200. View

3.
Rigottier-Gois L, Madec C, Navickas A, Matos R, Akary-Lepage E, Mistou M . The surface rhamnopolysaccharide epa of Enterococcus faecalis is a key determinant of intestinal colonization. J Infect Dis. 2014; 211(1):62-71. DOI: 10.1093/infdis/jiu402. View

4.
Kim J, Darlington A, Salvador M, Utrilla J, Jimenez J . Trade-offs between gene expression, growth and phenotypic diversity in microbial populations. Curr Opin Biotechnol. 2019; 62:29-37. PMC: 7208540. DOI: 10.1016/j.copbio.2019.08.004. View

5.
Gibson D, Young L, Chuang R, Venter J, Hutchison 3rd C, Smith H . Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009; 6(5):343-5. DOI: 10.1038/nmeth.1318. View